Strategic Partners A/S
OTC: OZYMF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jakob Færch Bendtsen
- Employees
- 1
- Headquarters
- Copenhagen, Denmark
- IPO year
- 2019
- Market cap
- $3.7M
- Website
- https://www.strategic-partners.dk
Loading OZYMF…
Loading profile data…Frequently asked questions about OZYMF
What does Strategic Partners A/S (OZYMF) do?
Initially operating as Orphazyme A/S, the company adopted its current name, Strategic Partners A/S, in October 2024. Established in 2009, this Danish entity is headquartered in Herlev. Historically, its primary focus was on biotechnology; however, it presently conducts no significant business operations.
Where does OZYMF trade?
Strategic Partners A/S (OZYMF) trades on the Other OTC.
What sector is OZYMF in?
Strategic Partners A/S (OZYMF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Strategic Partners A/S?
Jakob Færch Bendtsen is the chief executive officer of Strategic Partners A/S (OZYMF).
Where is Strategic Partners A/S headquartered?
Strategic Partners A/S is headquartered in Denmark.
Does OZYMF pay a dividend?
Strategic Partners A/S (OZYMF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OZYMF go public?
Strategic Partners A/S (OZYMF) completed its initial public offering in 2019.